Compare INSW & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INSW | CERT |
|---|---|---|
| Founded | 1999 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 1.4B |
| IPO Year | N/A | 2020 |
| Metric | INSW | CERT |
|---|---|---|
| Price | $48.32 | $9.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $48.00 | $13.25 |
| AVG Volume (30 Days) | 546.5K | ★ 2.4M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | ★ 6.06% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.39 | 0.07 |
| Revenue | ★ $770,036,000.00 | $415,551,000.00 |
| Revenue This Year | N/A | $10.82 |
| Revenue Next Year | $4.22 | $6.77 |
| P/E Ratio | ★ $11.02 | $134.09 |
| Revenue Growth | N/A | ★ 11.47 |
| 52 Week Low | $27.20 | $8.03 |
| 52 Week High | $55.18 | $15.69 |
| Indicator | INSW | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 38.95 | 47.95 |
| Support Level | $47.86 | $8.42 |
| Resistance Level | $49.30 | $9.17 |
| Average True Range (ATR) | 1.13 | 0.39 |
| MACD | -0.42 | 0.08 |
| Stochastic Oscillator | 12.97 | 53.60 |
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.